Non-invasive Drug Monitoring of β-Lactam Antibiotics Using Sweat Analysis—A Pilot Study
Background: Antimicrobial resistance is a major challenge in treating infectious diseases. Therapeutic drug monitoring (TDM) can optimize and personalize antibiotic treatment. Previously, antibiotic concentrations in tissues were extrapolated from skin blister studies, but sweat analyses for TDM hav...
Main Authors: | Noé Brasier, Andreas Widmer, Michael Osthoff, Markus Mutke, Fiorangelo De Ieso, Pascale Brasier-Lutz, Lisa Wolfe, Vikas Aithal, Corey D. Broeckling, Jessica Prenni, Jens Eckstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00476/full |
Similar Items
-
The Detection of Vancomycin in Sweat: A Next-Generation Digital Surrogate Marker for Antibiotic Tissue Penetration: A Pilot Study
by: Noé Brasier, et al.
Published: (2021-01-01) -
Sweat as a Source of Next-Generation Digital Biomarkers
by: Noé Brasier, et al.
Published: (2019-12-01) -
Device- and Analytics-Agnostic Infrastructure for Continuous Inpatient Monitoring: A Technical Note
by: Noé Brasier, et al.
Published: (2020-08-01) -
Dose-Adjusted Beta-Lactam Antibiotic-Induced Encephalopathy in a Patient with End-Stage Renal Impairment: A Case Report
by: Chris Anthony, et al.
Published: (2015-02-01) -
Were the English Sweating Sickness and the Picardy Sweat Caused by Hantaviruses?
by: Paul Heyman, et al.
Published: (2014-01-01)